Institute Scholar Peter Kim spent 12+ years helping develop and approve 20+ vaccines and medicines, including Gardasil and Keytruda. His lab at Stanford combines protein engineering and AI to design vaccines with broader, more durable immune protection: www.asbmb.org/asbmb-today/...

Show Post

I had a great time at the Covalent Drug Discovery Summit in Boston last week. Great to see, how residue-specific chemoproteomics has grown from the foundational work in the Cravatt lab to a technology that is routinely applied in many companies to drive covalent inhibitor development. (1/2)

Show Post

“The people who could do most to improve the situation of so many women and children are in fact, men. It's in our hands to stop violence towards women… I do what I do in my mother's name because I couldn't help her then. Now I can." Sir Patrick Stewart 💔

Show Post

Show Post

From an unexpected personal loss, to a pathology residency, to a defining conversation and more, Institute Scholar Paul Mischel traces the key turning points in his life and career in cancer research: www.nature.com/articles/s43... @natcancer.nature.com

Show Post